Home/Filings/4/0001578563-24-000325
4//SEC Filing

D'Adamio Anthony 4

Accession 0001578563-24-000325

CIK 0001665988other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 4:58 PM ET

Size

5.4 KB

Accession

0001578563-24-000325

Insider Transaction Report

Form 4
Period: 2024-06-21
D'Adamio Anthony
SVP & General Counsel
Transactions
  • Sale

    Class A Common Stock

    2024-06-21$5.57/sh5,904$32,88595,576 total
Footnotes (2)
  • [F1]Reflects shares sold to cover taxes upon the vesting of restricted stock units on June 20, 2024 pursuant to a standing 10b5-1 instruction adopted on June 20, 2023.
  • [F2]The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $5.515 to $5.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Bioventus Inc.

CIK 0001665988

Entity typeother

Related Parties

1
  • filerCIK 0001835184

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:58 PM ET
Size
5.4 KB